ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROMOTER INSERTION IN-VIVO

被引:2
|
作者
RAINERI, I
SOLER, M
SENN, HP
机构
[1] UNIV BASEL, INST MED MICROBIOL, CH-4003 BASEL, SWITZERLAND
[2] KANTONSSPITAL, DEPT INTERNAL MED, CH-4031 BASEL, SWITZERLAND
关键词
D O I
10.1006/viro.1995.1161
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Our study reports the occurrence of HIV-1 insertional activation events in vivo. Using a previously described PCR assay, small aliquots of broncho-alveolar lavage (BAL) cells obtained from AIDS patients were analyzed. Nine percent (5/54) of the aliquots contained proviral-host sequence transcripts indicating HIV-1 promoter insertion, whereas multiply spliced HIV-1 mRNAs were found in 28% (15/54) of the aliquots. In four of five events, insertions affect distinct cellular transcription units expressed in a T-cell line. To establish a ratio between provirus integration and promoter insertion events, an in vitro infection study was performed and transcripts containing HIV-1 and K-ras or CD4 gene sequences, respectively, were monitored. Given the randomness of retrovirus integration, 170 sense-oriented HIV integrations into these gene loci were predicted to occur. Three distinct promoter insertion events were observed, indicating that 1.8% of integrated proviruses transcribed adjacent genes. Based on this result and a mean of 257 proviral copies per 10(6) BAL cells, we would expect to observe 25 promoter insertion events in our in vivo study. That only five events were found may be due to the lower transcriptional activity of HIV-1 in vivo than that in cell cultures. (C) 1995 Academic Press, Inc.
引用
收藏
页码:359 / 364
页数:6
相关论文
共 50 条
  • [1] REQUIREMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF FOR IN-VIVO REPLICATION AND PATHOGENICITY
    JAMIESON, BD
    ALDROVANDI, GM
    PLANELLES, V
    JOWETT, JBM
    GAO, LY
    BLOCH, LM
    CHEN, ISY
    ZACK, JA
    JOURNAL OF VIROLOGY, 1994, 68 (06) : 3478 - 3485
  • [2] ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF GENE-SEQUENCES PRESENT IN-VIVO
    SHUGARS, DC
    SMITH, MS
    GLUECK, DH
    NANTERMET, PV
    SEILLIERMOISEIWITSCH, F
    SWANSTROM, R
    JOURNAL OF VIROLOGY, 1993, 67 (08) : 4639 - 4650
  • [3] DYNAMICS OF MOLECULAR-PARAMETERS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITY IN-VIVO
    BAGNARELLI, P
    VALENZA, A
    MENZO, S
    MANZIN, A
    SCALISE, G
    VARALDO, PE
    CLEMENTI, M
    JOURNAL OF VIROLOGY, 1994, 68 (04) : 2495 - 2502
  • [4] IN-VIVO PATHOGENIC PROPERTIES OF 2 CLONAL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES
    JAMIESON, BD
    PANG, S
    ALDROVANDI, GM
    ZHA, JL
    ZACK, JA
    JOURNAL OF VIROLOGY, 1995, 69 (10) : 6259 - 6264
  • [5] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 EVOLUTION IN-VIVO TRACKED BY DNA HETERODUPLEX MOBILITY ASSAYS
    DELWART, EL
    SHEPPARD, HW
    WALKER, BD
    GOUDSMIT, J
    MULLINS, JI
    JOURNAL OF VIROLOGY, 1994, 68 (10) : 6672 - 6683
  • [6] CONSERVATION OF AN INTACT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF GENE IN-VITRO AND IN-VIVO
    SOVA, P
    VANRANST, M
    GUPTA, P
    BALACHANDRAN, R
    CHAO, W
    ITESCU, S
    MCKINLEY, G
    VOLSKY, DJ
    JOURNAL OF VIROLOGY, 1995, 69 (04) : 2557 - 2564
  • [7] MORPHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CHATTERJEE, S
    BASAK, S
    KHAN, NC
    PATHOBIOLOGY, 1992, 60 (04) : 181 - 186
  • [8] A SYNTHETIC RETINOID ANTAGONIST INHIBITS THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROMOTER
    LEE, MO
    HOBBS, PD
    ZHANG, XK
    DAWSON, MI
    PFAHL, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (12) : 5632 - 5636
  • [9] RADIOSENSITIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CONWAY, B
    TOMFORD, WW
    CLINICAL INFECTIOUS DISEASES, 1992, 14 (04) : 978 - 979
  • [10] VARIANTS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    TOURNIER, JN
    VERRIER, B
    BIRON, FF
    MANDRAND, B
    PEYRAMOND, D
    MEDECINE ET MALADIES INFECTIEUSES, 1995, 25 (05): : 709 - 715